Life Sciences leaders are facing low single-digit growth in 2025. Research markets continue to struggle, largely due to sustained government funding cuts in the first half of the year. Applied markets have also tightened, though selective areas of growth remain.
Most organizations have completed cost-cutting across go-to-market functions (Marketing, Sales, Service and Revenue Operations) and are now shifting focus toward targeted investments that drive top-line growth.
As capital begins to return, leaders are re-evaluating their roles and account coverage strategies to better align resources by customer segment, product line, application and industry end-market.
I want to get going quickly once I buy … I do not want to spend time sharing my research information with a new person during onboarding.
We must be mindful of FAS capacity and cost. They’re being deployed for post-sales activities, but we are limiting any sort of ongoing support.
In an ideal future state, we receive one-third of revenue from field team, one-third from inside sales & one-third from a digital / ecommerce platform.